Evidence map›Paper›PMID 38467757›Full record

ArticleCellular and molecular life sciences : CMLS2024

Vascular ATGL-dependent lipolysis and the activation of cPLA

M Sternak, M Stojak, T Banasik, A Kij, A Bar, M Z Pacia, K Wojnar-Lason, N Chorazy, T Mohaissen, B Marczyk and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Lipid droplets and major metabolic disorders.Molecular biology reports · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

M SternakJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland. magdalena.sternak@jcet.eu.ORCID http://orcid.org/0000-0001-9690-5231
M StojakJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0003-2291-4068
T BanasikJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0009-0008-7972-8796
A KijJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0003-2233-0564
A BarJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0003-0182-6501
M Z PaciaJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0002-0391-2502
K Wojnar-LasonJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0002-9884-2032
N ChorazyJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0001-8597-0206
T MohaissenJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0001-7495-3945
B MarczykJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0001-9104-9528
I Czyzynska-CichonJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0000-0002-2684-1057
Z BerkimbayevaJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland.ORCID http://orcid.org/0009-0003-0288-9050
A MikaDepartment of Environmental Analysis, Faculty of Chemistry, University of Gdansk, Wita Stwosza 63, Gdansk, Poland.ORCID http://orcid.org/0000-0003-2877-5652
S ChlopickiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, Poland. stefan.chlopicki@jcet.eu.ORCID http://orcid.org/0000-0002-2878-3858
Jagiellonian University · PLUniversity of Gdańsk · PL

Funding

Narodowe Centrum Nauki UMO-2021/42/A/NZ4/00273
6 · The paper itself

Abstract

Adipose triglyceride lipase (ATGL) is involved in lipolysis and displays a detrimental pathophysiological role in cardio-metabolic diseases. However, the organo-protective effects of ATGL-induced lipolysis were also suggested. The aim of this work was to characterize the function of lipid droplets (LDs) and ATGL-induced lipolysis in the regulation of endothelial function. ATGL-dependent LDs hydrolysis and cytosolic phospholipase A

Indexed as

EicosanoidsLipolysisArachidonic AcidOlive OilPhospholipasesProstaglandins IArachidonic AcidEicosanoidsOlive OilPhospholipasesProstaglandins IATGLAtglistatinEndothelial-induced vasodilationEndotheliumLipid dropletsLipolysis

Identifiers

PMID38467757
PMCPMC10927860
OpenAlexW4392711500

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.